Paper618707
Determination of procainamide acetylator status.
Lima JJ and 1 other. Clin Pharmacol Ther, 1978. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Determination of procainamide acetylator status. Papers, record 618707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/618707
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Procainamide | Major topic |
| Acetylation | |
| Humans | |
| Infusions, Parenteral | |
| Kinetics | |
| Models, Biological | |
| Phenotype |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15793163 | Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15793163 | PubMed |
| 7389236 | Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/7389236 | PubMed |
| 7037261 | Drug metabolites in renal failure: pharmacokinetic and clinical implications. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/7037261 | PubMed |
| 6178545 | Clinical pharmacokinetics of N-acetylprocainamide. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/6178545 | PubMed |
| 6102499 | Clinical relevance of pharmacokinetics. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/6102499 | PubMed |
| 2598993 | Determination of acetylator phenotype in Caucasians with caffeine. | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2598993 | PubMed |
| 729620 | The pharmacokinetics of slow-release procainamide. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/729620 | PubMed |
| 729603 | Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/729603 | PubMed |
| 668789 | Pharmacokinetic approach to intravenous procainamide therapy. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/668789 | PubMed |
| 487686 | Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man. | Clin Pharmacokinet | 1979 | https://conductscience.org/library/papers/487686 | PubMed |
| 458558 | Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/458558 | PubMed |
| 28128 | Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole. | Clin Pharmacokinet | 1978 | https://conductscience.org/library/papers/28128 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/618707
GET https://conductscience.org/api/papers/v1/618707/authors